Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000885590-12-000075
Filing Date
2012-11-09
Accepted
2012-11-09 15:53:26
Documents
1
Period of Report
2012-11-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 7617
  Complete submission text file 0000885590-12-000075.txt   9172
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4787 LEVY STREET MONTREAL A8 H4R 2P9
Business Address
DE SILVA RAJIV (Reporting) CIK: 0001453140 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 121193577